CN
CN
Core Principles Driving Our Mission
  • Global Impact, Local Insight

    Leverage our international presence to address global health challenges with regionally relevant, scalable solutions.


  • Relentless Scientific Innovation

    Advance the frontiers of biotechnology through continuous R&D, pioneering new diagnostics, and technologies.

  • Precision & Quality Without Compromise

    Deliver rigorously validated, high-accuracy solutions that meet the highest scientific and clinical standards.

  • Regulatory Excellence

    Ensure full compliance with global regulatory frameworks, prioritizing patient safety, data integrity, and ethical responsibility.


  • Patient-Centric

    Develop every product and solution with the needs of patients at the center.


  • Collaborative Discovery

    Build strategic alliances across academia, industry, and healthcare to accelerate breakthroughs and shared success.


Colosafe ®
Methylation Detection Kit for Human SDC2 Gene(Real time PCR)， It was the first approved of its kind by NMPA on November 20, 2018.
Read more
First NMPA-approved stool DNA test kit for early detection of colorectal cancer
Product Pipeline
Lunsafe®
Read more
Automatic Sample Preprocessing Instrument
Read more
Automatic Nucleic Acid Extraction Instrument H24
Read more
HemoPOC® Coagulometer
Read more
HelixPOC® Automated Microfluidic qPCR System
Read more
Colosafe ®
Publications
1 .Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal Neoplasia
2 .Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection a multicenter clinical study
3 .A novel stool-based SDC2 DNA methylation test is more robust than FIT and plasma CEA in detecting colorectal neoplasia in China
Media Center
Lunsafe® Wins NMPA Approval, Pioneering Noninvasive Early Detection of Lung Cancer in China
Jun 01, 2025

Guangzhou, China – May 30, 2025 – Creative Biosciences (Guangzhou) CO., Ltd. today announced that its independently developed methylation test kit for the early detection of lung cancer, Lunsafe, has received official approval from China’s National Medic

Read more

No. 10 Fenghuang Wu Road
Huangpu District
Guangzhou, Guangdong, 510555
P.R. China


Contact us at

T: +001-206-717-2769
Email: info@creativebio.cn


copyright ©2025 Creative Biosciences (Guangzhou) CO., Ltd
Legal mention